ARBEL IRIT 4
4 · BRAINSTORM CELL THERAPEUTICS INC. · Filed Nov 30, 2018
Insider Transaction Report
Form 4
ARBEL IRIT
Director
Transactions
- Award
Stock Option (right to buy)
2018-11-30+25,333→ 25,333 totalExercise: $0.75From: 2018-12-30Exp: 2028-11-30→ Common Stock (25,333 underlying)
Footnotes (1)
- [F1]Option vests and becomes exercisable in 12 consecutive, equal monthly installments commencing on December 30, 2018 until fully vested and exercisable on November 30, 2019, provided that the reporting person remains a director of Brainstorm Cell Therapeutics on each vesting date.